GO:0043087 | regulation of GTPase activity | 2.73% (3/110) | 5.88 | 2.1e-05 | 0.000903 |
GO:0035515 | oxidative RNA demethylase activity | 1.82% (2/110) | 8.29 | 2e-05 | 0.000941 |
GO:0035516 | oxidative DNA demethylase activity | 1.82% (2/110) | 8.29 | 2e-05 | 0.000941 |
GO:0035552 | oxidative single-stranded DNA demethylation | 1.82% (2/110) | 8.29 | 2e-05 | 0.000941 |
GO:0035513 | oxidative RNA demethylation | 1.82% (2/110) | 8.29 | 2e-05 | 0.000941 |
GO:0070989 | oxidative demethylation | 1.82% (2/110) | 8.29 | 2e-05 | 0.000941 |
GO:0004018 | N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity | 1.82% (2/110) | 9.17 | 6e-06 | 0.000993 |
GO:0005506 | iron ion binding | 6.36% (7/110) | 3.05 | 2.5e-05 | 0.001006 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 3.64% (4/110) | 5.29 | 4e-06 | 0.001033 |
GO:0005634 | nucleus | 13.64% (15/110) | 1.88 | 1.4e-05 | 0.00122 |
GO:0090630 | activation of GTPase activity | 2.73% (3/110) | 6.9 | 2e-06 | 0.001293 |
GO:0016842 | amidine-lyase activity | 1.82% (2/110) | 7.58 | 5.3e-05 | 0.001319 |
GO:0016040 | glutamate synthase (NADH) activity | 1.82% (2/110) | 7.61 | 5.1e-05 | 0.001336 |
GO:0045181 | glutamate synthase activity, NAD(P)H as acceptor | 1.82% (2/110) | 7.61 | 5.1e-05 | 0.001336 |
GO:0051336 | regulation of hydrolase activity | 2.73% (3/110) | 5.38 | 5.7e-05 | 0.00137 |
GO:0051345 | positive regulation of hydrolase activity | 2.73% (3/110) | 6.09 | 1.3e-05 | 0.001384 |
GO:0019676 | ammonia assimilation cycle | 1.82% (2/110) | 7.63 | 4.9e-05 | 0.001432 |
GO:0019740 | nitrogen utilization | 1.82% (2/110) | 7.63 | 4.9e-05 | 0.001432 |
GO:0141067 | intracellular nitrogen homeostasis | 1.82% (2/110) | 7.63 | 4.9e-05 | 0.001432 |
GO:0016491 | oxidoreductase activity | 10.91% (12/110) | 1.96 | 6.3e-05 | 0.001437 |
GO:0043547 | positive regulation of GTPase activity | 2.73% (3/110) | 6.17 | 1.1e-05 | 0.001484 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.82% (2/110) | 7.77 | 4e-05 | 0.001519 |
GO:0051213 | dioxygenase activity | 3.64% (4/110) | 4.23 | 7e-05 | 0.001525 |
GO:0140513 | nuclear protein-containing complex | 8.18% (9/110) | 2.46 | 4.4e-05 | 0.001529 |
GO:0015930 | glutamate synthase activity | 1.82% (2/110) | 7.13 | 9.9e-05 | 0.002079 |
GO:0005684 | U2-type spliceosomal complex | 2.73% (3/110) | 5.03 | 0.000116 | 0.002353 |
GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity | 1.82% (2/110) | 6.76 | 0.000166 | 0.003228 |
GO:0071949 | FAD binding | 2.73% (3/110) | 4.81 | 0.000182 | 0.003308 |
GO:0008047 | enzyme activator activity | 3.64% (4/110) | 3.87 | 0.00018 | 0.003389 |
GO:0140677 | molecular function activator activity | 3.64% (4/110) | 3.78 | 0.000228 | 0.003743 |
GO:0140097 | catalytic activity, acting on DNA | 5.45% (6/110) | 2.81 | 0.000239 | 0.003815 |
GO:0006537 | glutamate biosynthetic process | 1.82% (2/110) | 6.53 | 0.000226 | 0.003835 |
GO:0043085 | positive regulation of catalytic activity | 2.73% (3/110) | 4.71 | 0.000223 | 0.003918 |
GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.82% (2/110) | 6.45 | 0.000254 | 0.003923 |
GO:0044093 | positive regulation of molecular function | 2.73% (3/110) | 4.61 | 0.000275 | 0.004016 |
GO:0006574 | valine catabolic process | 1.82% (2/110) | 6.39 | 0.000274 | 0.00412 |
GO:0080111 | DNA demethylation | 1.82% (2/110) | 6.3 | 0.000313 | 0.004453 |
GO:0035514 | DNA demethylase activity | 1.82% (2/110) | 6.2 | 0.00036 | 0.004979 |
GO:0120253 | hydrocarbon catabolic process | 1.82% (2/110) | 6.09 | 0.000414 | 0.005069 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 8.18% (9/110) | 2.02 | 0.000409 | 0.005125 |
GO:0016121 | carotene catabolic process | 1.82% (2/110) | 6.11 | 0.000404 | 0.005185 |
GO:0046247 | terpene catabolic process | 1.82% (2/110) | 6.11 | 0.000404 | 0.005185 |
GO:0010436 | carotenoid dioxygenase activity | 1.82% (2/110) | 6.11 | 0.000404 | 0.005185 |
GO:0005096 | GTPase activator activity | 2.73% (3/110) | 4.36 | 0.000453 | 0.005414 |
GO:0004843 | cysteine-type deubiquitinase activity | 2.73% (3/110) | 4.34 | 0.000475 | 0.005427 |
GO:0035510 | DNA dealkylation | 1.82% (2/110) | 6.01 | 0.000467 | 0.005464 |
GO:0070647 | protein modification by small protein conjugation or removal | 5.45% (6/110) | 2.61 | 0.000489 | 0.005477 |
GO:0006573 | valine metabolic process | 1.82% (2/110) | 5.96 | 0.000501 | 0.005488 |
GO:0006541 | glutamine metabolic process | 1.82% (2/110) | 5.91 | 0.000535 | 0.005745 |
GO:0008198 | ferrous iron binding | 1.82% (2/110) | 5.86 | 0.000571 | 0.006005 |
GO:0003674 | molecular_function | 50.91% (56/110) | 0.53 | 0.000589 | 0.006078 |
GO:0101005 | deubiquitinase activity | 2.73% (3/110) | 4.22 | 0.000603 | 0.0061 |
GO:0016289 | CoA hydrolase activity | 1.82% (2/110) | 5.8 | 0.00062 | 0.006153 |
GO:0016119 | carotene metabolic process | 1.82% (2/110) | 5.72 | 0.000691 | 0.006728 |
GO:0016579 | protein deubiquitination | 2.73% (3/110) | 4.13 | 0.000716 | 0.006846 |
GO:0006536 | glutamate metabolic process | 1.82% (2/110) | 5.58 | 0.000844 | 0.007784 |
GO:0006188 | IMP biosynthetic process | 1.82% (2/110) | 5.59 | 0.000829 | 0.007787 |
GO:0019783 | ubiquitin-like protein peptidase activity | 2.73% (3/110) | 4.01 | 0.000909 | 0.008103 |
GO:0008300 | isoprenoid catabolic process | 1.82% (2/110) | 5.53 | 0.000895 | 0.008119 |
GO:0046040 | IMP metabolic process | 1.82% (2/110) | 5.49 | 0.000949 | 0.008315 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.64% (4/110) | 3.14 | 0.001179 | 0.009117 |
GO:0043650 | dicarboxylic acid biosynthetic process | 1.82% (2/110) | 5.34 | 0.001168 | 0.009167 |
GO:0120252 | hydrocarbon metabolic process | 1.82% (2/110) | 5.34 | 0.001159 | 0.009238 |
GO:0009083 | branched-chain amino acid catabolic process | 1.82% (2/110) | 5.4 | 0.001076 | 0.009276 |
GO:1901605 | alpha-amino acid metabolic process | 3.64% (4/110) | 3.15 | 0.001149 | 0.0093 |
GO:0070646 | protein modification by small protein removal | 2.73% (3/110) | 3.89 | 0.001147 | 0.009426 |
GO:0042214 | terpene metabolic process | 1.82% (2/110) | 5.35 | 0.001142 | 0.009537 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 2.73% (3/110) | 3.9 | 0.001126 | 0.009554 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.82% (2/110) | 5.25 | 0.001326 | 0.009555 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 1.82% (2/110) | 5.25 | 0.001326 | 0.009555 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.82% (2/110) | 5.25 | 0.001317 | 0.009757 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.82% (2/110) | 5.25 | 0.001317 | 0.009757 |
GO:0042254 | ribosome biogenesis | 1.82% (2/110) | 5.26 | 0.001308 | 0.009971 |
GO:0043687 | post-translational protein modification | 5.45% (6/110) | 2.31 | 0.001421 | 0.0101 |
GO:0005488 | binding | 35.45% (39/110) | 0.65 | 0.001447 | 0.010149 |
GO:0070988 | demethylation | 1.82% (2/110) | 5.09 | 0.001631 | 0.010465 |
GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors | 1.82% (2/110) | 5.08 | 0.001652 | 0.010466 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.82% (2/110) | 5.1 | 0.001621 | 0.010529 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 6.36% (7/110) | 2.07 | 0.001529 | 0.010579 |
GO:0006304 | DNA modification | 1.82% (2/110) | 5.07 | 0.001692 | 0.010596 |
GO:0016840 | carbon-nitrogen lyase activity | 1.82% (2/110) | 5.06 | 0.001713 | 0.010597 |
GO:0030695 | GTPase regulator activity | 2.73% (3/110) | 3.72 | 0.00162 | 0.010649 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 2.73% (3/110) | 3.72 | 0.00162 | 0.010649 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 1.82% (2/110) | 5.11 | 0.001592 | 0.010733 |
GO:0001098 | basal transcription machinery binding | 1.82% (2/110) | 5.11 | 0.001592 | 0.010733 |
GO:0050790 | regulation of catalytic activity | 2.73% (3/110) | 3.66 | 0.001823 | 0.011149 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.82% (2/110) | 4.95 | 0.001989 | 0.011889 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 1.82% (2/110) | 4.95 | 0.001978 | 0.011959 |
GO:0065009 | regulation of molecular function | 2.73% (3/110) | 3.6 | 0.002054 | 0.012006 |
GO:0016790 | thiolester hydrolase activity | 1.82% (2/110) | 4.93 | 0.002033 | 0.012017 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.82% (2/110) | 4.86 | 0.00225 | 0.012865 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 1.82% (2/110) | 4.86 | 0.002238 | 0.012939 |
GO:0046914 | transition metal ion binding | 7.27% (8/110) | 1.79 | 0.002367 | 0.013385 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4.55% (5/110) | 2.41 | 0.002676 | 0.014975 |
GO:0005681 | spliceosomal complex | 2.73% (3/110) | 3.44 | 0.002777 | 0.015375 |
GO:0009081 | branched-chain amino acid metabolic process | 1.82% (2/110) | 4.67 | 0.002897 | 0.015871 |
GO:0006289 | nucleotide-excision repair | 1.82% (2/110) | 4.6 | 0.003166 | 0.016992 |
GO:0050660 | flavin adenine dinucleotide binding | 2.73% (3/110) | 3.37 | 0.003198 | 0.016993 |
GO:0003824 | catalytic activity | 29.09% (32/110) | 0.68 | 0.003245 | 0.017071 |
GO:0061630 | ubiquitin protein ligase activity | 2.73% (3/110) | 3.38 | 0.003153 | 0.0171 |
GO:0043226 | organelle | 16.36% (18/110) | 1.0 | 0.003453 | 0.017809 |
GO:0043229 | intracellular organelle | 16.36% (18/110) | 1.0 | 0.00345 | 0.017965 |
GO:0061659 | ubiquitin-like protein ligase activity | 2.73% (3/110) | 3.32 | 0.003554 | 0.018149 |
GO:0009991 | response to extracellular stimulus | 1.82% (2/110) | 4.47 | 0.003797 | 0.019023 |
GO:0031667 | response to nutrient levels | 1.82% (2/110) | 4.47 | 0.003782 | 0.019131 |
GO:0008234 | cysteine-type peptidase activity | 2.73% (3/110) | 3.27 | 0.00392 | 0.019451 |
GO:0009064 | glutamine family amino acid metabolic process | 1.82% (2/110) | 4.39 | 0.004212 | 0.020704 |
GO:0030234 | enzyme regulator activity | 3.64% (4/110) | 2.62 | 0.004303 | 0.020766 |
GO:0043231 | intracellular membrane-bounded organelle | 14.55% (16/110) | 1.05 | 0.00429 | 0.020893 |
GO:0009910 | negative regulation of flower development | 0.91% (1/110) | 7.77 | 0.004566 | 0.021638 |
GO:0043227 | membrane-bounded organelle | 14.55% (16/110) | 1.04 | 0.00461 | 0.021649 |
GO:0032451 | demethylase activity | 1.82% (2/110) | 4.34 | 0.004548 | 0.021746 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1.82% (2/110) | 4.31 | 0.004728 | 0.02201 |
GO:0001096 | TFIIF-class transcription factor complex binding | 0.91% (1/110) | 7.66 | 0.004931 | 0.02275 |
GO:0032991 | protein-containing complex | 10.91% (12/110) | 1.24 | 0.00505 | 0.0231 |
GO:1902680 | positive regulation of RNA biosynthetic process | 2.73% (3/110) | 3.12 | 0.005175 | 0.023263 |
GO:0045893 | positive regulation of DNA-templated transcription | 2.73% (3/110) | 3.12 | 0.005175 | 0.023263 |
GO:0098772 | molecular function regulator activity | 3.64% (4/110) | 2.53 | 0.005381 | 0.023985 |
GO:0071006 | U2-type catalytic step 1 spliceosome | 0.91% (1/110) | 7.51 | 0.005477 | 0.024008 |
GO:0071012 | catalytic step 1 spliceosome | 0.91% (1/110) | 7.51 | 0.005477 | 0.024008 |
GO:0050793 | regulation of developmental process | 1.82% (2/110) | 4.18 | 0.005573 | 0.024228 |
GO:0048581 | negative regulation of post-embryonic development | 0.91% (1/110) | 7.46 | 0.005659 | 0.024399 |
GO:0016706 | 2-oxoglutarate-dependent dioxygenase activity | 1.82% (2/110) | 4.15 | 0.005845 | 0.024794 |
GO:0006807 | nitrogen compound metabolic process | 20.91% (23/110) | 0.79 | 0.005806 | 0.02483 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.82% (13/110) | 1.14 | 0.005979 | 0.02516 |
GO:0003682 | chromatin binding | 2.73% (3/110) | 3.02 | 0.00624 | 0.025845 |
GO:0005674 | transcription factor TFIIF complex | 0.91% (1/110) | 7.33 | 0.006205 | 0.025904 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.82% (2/110) | 4.08 | 0.006425 | 0.026197 |
GO:0006357 | regulation of transcription by RNA polymerase II | 3.64% (4/110) | 2.46 | 0.006385 | 0.026237 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.82% (2/110) | 4.07 | 0.006521 | 0.026384 |
GO:0018130 | heterocycle biosynthetic process | 4.55% (5/110) | 2.05 | 0.007581 | 0.030439 |
GO:0099122 | RNA polymerase II C-terminal domain binding | 0.91% (1/110) | 6.99 | 0.007841 | 0.03078 |
GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding | 0.91% (1/110) | 6.99 | 0.007841 | 0.03078 |
GO:0050815 | phosphoserine residue binding | 0.91% (1/110) | 6.99 | 0.007841 | 0.03078 |
GO:0045309 | protein phosphorylated amino acid binding | 0.91% (1/110) | 6.96 | 0.008023 | 0.03103 |
GO:0051219 | phosphoprotein binding | 0.91% (1/110) | 6.96 | 0.008023 | 0.03103 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.82% (2/110) | 3.9 | 0.0081 | 0.0311 |
GO:0051254 | positive regulation of RNA metabolic process | 2.73% (3/110) | 2.87 | 0.008362 | 0.031873 |
GO:0070939 | Dsl1/NZR complex | 0.91% (1/110) | 6.86 | 0.008568 | 0.032421 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.82% (2/110) | 3.82 | 0.009015 | 0.032702 |
GO:1901606 | alpha-amino acid catabolic process | 1.82% (2/110) | 3.81 | 0.009127 | 0.032881 |
GO:0044877 | protein-containing complex binding | 3.64% (4/110) | 2.31 | 0.009004 | 0.03289 |
GO:0009891 | positive regulation of biosynthetic process | 2.73% (3/110) | 2.83 | 0.009001 | 0.033107 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 2.73% (3/110) | 2.83 | 0.009001 | 0.033107 |
GO:0031328 | positive regulation of cellular biosynthetic process | 2.73% (3/110) | 2.83 | 0.009001 | 0.033107 |
GO:0019438 | aromatic compound biosynthetic process | 4.55% (5/110) | 1.98 | 0.009288 | 0.033236 |
GO:0000149 | SNARE binding | 1.82% (2/110) | 3.84 | 0.008859 | 0.033286 |
GO:0000209 | protein polyubiquitination | 1.82% (2/110) | 3.79 | 0.009375 | 0.033319 |
GO:0140098 | catalytic activity, acting on RNA | 4.55% (5/110) | 1.97 | 0.009548 | 0.033708 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 2.73% (3/110) | 2.79 | 0.0097 | 0.034015 |
GO:2000242 | negative regulation of reproductive process | 0.91% (1/110) | 6.66 | 0.009837 | 0.034268 |
GO:0009063 | amino acid catabolic process | 1.82% (2/110) | 3.72 | 0.010397 | 0.03598 |
GO:0046975 | histone H3K36 methyltransferase activity | 0.91% (1/110) | 6.56 | 0.010562 | 0.036076 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.82% (2/110) | 3.69 | 0.010733 | 0.036188 |
GO:1901565 | organonitrogen compound catabolic process | 3.64% (4/110) | 2.24 | 0.010554 | 0.036284 |
GO:0006520 | amino acid metabolic process | 3.64% (4/110) | 2.24 | 0.010693 | 0.036288 |
GO:0051093 | negative regulation of developmental process | 0.91% (1/110) | 6.48 | 0.011106 | 0.037207 |
GO:0051241 | negative regulation of multicellular organismal process | 0.91% (1/110) | 6.46 | 0.011286 | 0.037574 |
GO:0050000 | chromosome localization | 0.91% (1/110) | 6.35 | 0.012191 | 0.039101 |
GO:0034397 | telomere localization | 0.91% (1/110) | 6.35 | 0.012191 | 0.039101 |
GO:0034398 | telomere tethering at nuclear periphery | 0.91% (1/110) | 6.35 | 0.012191 | 0.039101 |
GO:1901575 | organic substance catabolic process | 5.45% (6/110) | 1.66 | 0.012309 | 0.039241 |
GO:0043648 | dicarboxylic acid metabolic process | 1.82% (2/110) | 3.61 | 0.011867 | 0.039259 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.82% (2/110) | 3.61 | 0.011968 | 0.039346 |
GO:0042393 | histone binding | 1.82% (2/110) | 3.6 | 0.01207 | 0.039433 |
GO:0044238 | primary metabolic process | 22.73% (25/110) | 0.66 | 0.01257 | 0.039591 |
GO:0008360 | regulation of cell shape | 0.91% (1/110) | 6.31 | 0.012553 | 0.039776 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.82% (2/110) | 3.5 | 0.013825 | 0.043029 |
GO:0097747 | RNA polymerase activity | 1.82% (2/110) | 3.5 | 0.013825 | 0.043029 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.55% (5/110) | 1.83 | 0.013984 | 0.043269 |
GO:0006139 | nucleobase-containing compound metabolic process | 10.0% (11/110) | 1.09 | 0.014617 | 0.044702 |
GO:0032774 | RNA biosynthetic process | 2.73% (3/110) | 2.57 | 0.014608 | 0.044936 |
GO:2001141 | regulation of RNA biosynthetic process | 6.36% (7/110) | 1.45 | 0.014976 | 0.045271 |
GO:0006355 | regulation of DNA-templated transcription | 6.36% (7/110) | 1.45 | 0.014976 | 0.045271 |
GO:0030880 | RNA polymerase complex | 1.82% (2/110) | 3.42 | 0.01523 | 0.045778 |
GO:0009056 | catabolic process | 5.45% (6/110) | 1.59 | 0.015378 | 0.045958 |
GO:0004842 | ubiquitin-protein transferase activity | 2.73% (3/110) | 2.52 | 0.015762 | 0.046842 |
GO:0031325 | positive regulation of cellular metabolic process | 2.73% (3/110) | 2.52 | 0.015996 | 0.047269 |
GO:0008187 | poly-pyrimidine tract binding | 0.91% (1/110) | 5.92 | 0.016342 | 0.048022 |
GO:0044614 | nuclear pore cytoplasmic filaments | 0.91% (1/110) | 5.91 | 0.016522 | 0.048282 |